drugset / Trial / NCT06165692

The Use of Platelet-rich-fibrin in Lower Third Molar Surgery.

NCT06165692

Completed 31 enrolled Amerigo Giudice
RandomizedCrossoverTriple-blindTreatment

Summary

The present study aims to analyze the effect of PRF (Platelet-rich-fibrin) in terms of facial swelling, trismus and pain after surgical removal of mandibular third molar (M3M) in a split-mouth randomized controlled clinical trial.

Timeline

Start
2022-10-01
Primary completion
2023-10-01
Completion
2023-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Concentrate Other / unclassified